Bisphosphonate nephrotoxicity.
Perazella MA, Markowitz GS.
Kidney Int. 2008 Dec;74(11):1385-93. doi: 10.1038/ki.2008.356. Epub 2008 Aug 6.
Hypercalcemia of malignancy.
Insogna KL, Broadus AE.
Annu Rev Med. 1987;38:241-56. doi: 10.1146/annurev.me.38.020187.001325.
Animal Models of Cancer-Associated Hypercalcemia.
Kohart NA, Elshafae SM, Breitbach JT, Rosol TJ.
Vet Sci. 2017 Apr 13;4(2):21. doi: 10.3390/vetsci4020021.
Molecular Regulation of Bone Metastasis Pathogenesis.
Wu MY, Li CJ, Yiang GT, Cheng YL, Tsai AP, Hou YT, Ho YC, Hou MF, Chu PY.
Cell Physiol Biochem. 2018;46(4):1423-1438. doi: 10.1159/000489184. Epub 2018 Apr 18.
HTLV-1 infected T cells cause bone loss via small extracellular vesicles.
Pokhrel NK, Panfil AR, Habib H, Seeniraj S, Joseph A, Rauch D, Cox L, Sprung R, Gilmore PE, Zhang Q, Townsend RR, Yu L, Yilmaz AS, Aurora R, Park W, Ratner L, Weilbaecher KN, Veis DJ.
J Extracell Vesicles. 2024 Oct;13(10):e12516. doi: 10.1002/jev2.12516.
Clodronate news of efficacy in osteoporosis.
Nardi A, Ventura L, Cozzi L, Tonini G.
Clin Cases Miner Bone Metab. 2016 Jan-Apr;13(1):33-5. doi: 10.11138/ccmbm/2016.13.1.033. Epub 2016 May 11.
[Treatment of malignancy associated hypercalcemia].
Tai N, Inoue D.
Clin Calcium. 2014 Aug;24(8):1223-8.
Osteolytic Lesions: An Unexpected Diagnosis.
Mesquita P, Ferreira da Silva D, Mateus S, Costa TM, Ferrão Vale L.
Cureus. 2025 Feb 28;17(2):e79808. doi: 10.7759/cureus.79808. eCollection 2025 Feb.
Management of complications in multiple myeloma.
Terpos E, Cibeira MT, Blade J, Ludwig H.
Semin Hematol. 2009 Apr;46(2):176-89. doi: 10.1053/j.seminhematol.2009.01.005.
New insights in myeloma-induced osteolysis.
Barillé-Nion S, Bataille R.
Leuk Lymphoma. 2003 Sep;44(9):1463-7. doi: 10.3109/10428190309178765.
